We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

High Court Seeks US Take On Sandoz-Amgen Biosimilar Battle

Law360, New York (June 20, 2016, 1:35 PM EDT) -- The U.S. Supreme Court on Monday asked the U.S. solicitor general whether it should review a Federal Circuit ruling on the obligations of biosimilar makers, signaling that the justices are interested...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.